Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arrowhead Pharmaceuticals (ARWR) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for Arrowhead Pharmaceuticals (ARWR) over the last 16 years, with Q4 2025 value amounting to $22.9 million.

  • Arrowhead Pharmaceuticals' Prepaid Assets rose 14402.09% to $22.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $22.9 million, marking a year-over-year increase of 14402.09%. This contributed to the annual value of $13.5 million for FY2025, which is 4172.17% up from last year.
  • Arrowhead Pharmaceuticals' Prepaid Assets amounted to $22.9 million in Q4 2025, which was up 14402.09% from $13.5 million recorded in Q3 2025.
  • Arrowhead Pharmaceuticals' Prepaid Assets' 5-year high stood at $25.2 million during Q4 2022, with a 5-year trough of $4.4 million in Q3 2021.
  • Over the past 5 years, Arrowhead Pharmaceuticals' median Prepaid Assets value was $9.8 million (recorded in 2023), while the average stood at $12.6 million.
  • In the last 5 years, Arrowhead Pharmaceuticals' Prepaid Assets surged by 38447.78% in 2022 and then crashed by 5825.0% in 2023.
  • Quarter analysis of 5 years shows Arrowhead Pharmaceuticals' Prepaid Assets stood at $5.2 million in 2021, then skyrocketed by 384.48% to $25.2 million in 2022, then crashed by 58.25% to $10.5 million in 2023, then fell by 10.94% to $9.4 million in 2024, then skyrocketed by 144.02% to $22.9 million in 2025.
  • Its last three reported values are $22.9 million in Q4 2025, $13.5 million for Q3 2025, and $23.7 million during Q2 2025.